La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

CONMED Gestion

Gestion contrôle des critères 3/4

Le PDG CONMED's est Curt Hartman, nommé en Jul2014, a un mandat de 10.08 ans. La rémunération annuelle totale est $ 7.76M, composée du salaire de 12.2% et des bonus 87.8%, y compris les actions et options de la société. détient directement 0.28% des actions de la société, d'une valeur de $ 5.99M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 9.3 ans et 9.1 ans.

Informations clés

Curt Hartman

Directeur général

US$7.8m

Rémunération totale

Pourcentage du salaire du PDG	12.2%
Durée du mandat du directeur général	10.1yrs
Propriété du PDG	0.3%
Durée moyenne d'occupation des postes de direction	9.3yrs
Durée moyenne du mandat des membres du conseil d'administration	9.1yrs

Mises à jour récentes de la gestion

Recent updates

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Aug 15

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

Jul 17

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18

CONMED declares $0.20 dividend

Aug 11

Analyse de la rémunération des PDG

Comment la rémunération de Curt Hartman a-t-elle évolué par rapport aux bénéfices de CONMED?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	n/a	n/a	US$99m
Mar 31 2024	n/a	n/a	US$82m
Dec 31 2023	US$8m	US$950k	US$64m
Sep 30 2023	n/a	n/a	US$58m
Jun 30 2023	n/a	n/a	US$88m
Mar 31 2023	n/a	n/a	-US$94m
Dec 31 2022	US$8m	US$946k	-US$81m
Sep 30 2022	n/a	n/a	-US$83m
Jun 30 2022	n/a	n/a	-US$114m
Mar 31 2022	n/a	n/a	US$68m
Dec 31 2021	US$9m	US$918k	US$63m
Sep 30 2021	n/a	n/a	US$62m
Jun 30 2021	n/a	n/a	US$54m
Mar 31 2021	n/a	n/a	US$13m
Dec 31 2020	US$6m	US$888k	US$10m
Sep 30 2020	n/a	n/a	US$311k
Jun 30 2020	n/a	n/a	US$431k
Mar 31 2020	n/a	n/a	US$34m
Dec 31 2019	US$6m	US$842k	US$29m
Sep 30 2019	n/a	n/a	US$29m
Jun 30 2019	n/a	n/a	US$28m
Mar 31 2019	n/a	n/a	US$31m
Dec 31 2018	US$5m	US$791k	US$41m
Sep 30 2018	n/a	n/a	US$72m
Jun 30 2018	n/a	n/a	US$73m
Mar 31 2018	n/a	n/a	US$71m
Dec 31 2017	US$3m	US$753k	US$55m

Rémunération vs marché: La rémunération totale de Curt ($USD 7.76M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 5.62M ).

Rémunération et revenus: La rémunération de Curt a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Curt Hartman (60 yo)

10.1yrs

Titularisation

US$7,764,615

Compensation

Mr. Curt R. Hartman has been Chairman of the Board at CONMED Corporation since May 21, 2020. Mr. Hartman has been the Chief Executive Officer and President of CONMED Corporation since November 09, 2014. Mr...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Curt Hartman	Chairman of the Board	10.1yrs	US$7.76m	0.28% $ 6.0m
Todd Garner	Executive VP of Finance & CFO	6.6yrs	US$2.87m	0.00074% $ 15.6k
Patrick Beyer	Chief Operating Officer	less than a year	US$3.30m	0.035% $ 736.8k
Stanley Peters	President of Advanced Surgical & Advanced Endoscopic Technologies	9.6yrs	US$2.00m	0.0048% $ 101.3k
Richard Glaze	Chief Information Officer	no data	pas de données	pas de données
Peter Shagory	Executive Vice President of Strategy & Corporate Development	9.3yrs	pas de données	0.012% $ 253.1k
Shanna Cotti-Osmanski	Executive VP of Information Technology & CIO	4.4yrs	pas de données	pas de données
John Ferrell	Executive Vice President of Human Resources	1.7yrs	pas de données	0.0023% $ 47.9k
Daniel Jonas	Special Counsel & Corporate Secretary	6.3yrs	US$1.55m	0.044% $ 918.1k
David Murray	President of ConMed Electrosurgery	20.1yrs	US$572.33k	pas de données
Terence Berge	VP & Corporate Controller	9.3yrs	pas de données	0.0033% $ 68.5k
Johonna Pelletier	VP of Tax & Treasurer	9.3yrs	pas de données	0.0043% $ 89.8k

9.3yrs

Durée moyenne de l'emploi

55.5yo

Âge moyen

Gestion expérimentée: L'équipe de direction de CNMD est chevronnée et expérimentée (ancienneté moyenne 9.3 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Curt Hartman	Chairman of the Board	10.4yrs	US$7.76m	0.28% $ 6.0m
John Workman	Independent Director	9.1yrs	US$257.37k	0.066% $ 1.4m
David Bronson	Independent Director	9.1yrs	US$264.87k	0.054% $ 1.1m
Brian Concannon	Independent Director	11.1yrs	US$257.37k	0.031% $ 657.2k
LaVerne Council	Independent Director	4.7yrs	US$257.37k	0.012% $ 243.4k
Martha Aronson	Lead Independent Director	8.5yrs	US$292.37k	0.045% $ 948.7k
Charles Farkas	Independent Director	10.1yrs	US$249.87k	0.064% $ 1.4m
Barbara Schwarzentraub	Independent Director	4.9yrs	US$264.87k	0.017% $ 361.8k

9.1yrs

Durée moyenne de l'emploi

64yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de CNMD sont considérés comme expérimentés (ancienneté moyenne 9.1 ans).

CONMED Gestion

Gestion contrôle des critères 3/4

Informations clés

Mises à jour récentes de la gestion

CONMED Corporation Announces Termination of Stanley W. (Bill) Peters as President, Advanced Surgical & Advanced Endoscopic Technologies, Effective August 31, 2024

Insider notifies of intention to sell stock

CONMED Corporation, Annual General Meeting, May 22, 2024

Insider exercised options and sold US$721k worth of stock

Insider notifies of intention to sell stock

Insider notifies of intention to sell stock

Recent updates

CONMED Corporation Announces Termination of Stanley W. (Bill) Peters as President, Advanced Surgical & Advanced Endoscopic Technologies, Effective August 31, 2024

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Second quarter dividend of US$0.20 announced

Consensus EPS estimates increase by 10%, revenue downgraded

Price target decreased by 8.8% to US$84.25

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

CONMED Corporation to Report Q2, 2024 Results on Jul 31, 2024

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Insider notifies of intention to sell stock

Upcoming dividend of US$0.20 per share

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

First quarter dividend of US$0.20 announced

CONMED Corporation Declares Quarterly Cash Dividend, Payable on July 5, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

CONMED Corporation, Annual General Meeting, May 22, 2024

CONMED Corporation to Report Q1, 2024 Results on Apr 24, 2024

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Insider exercised options and sold US$721k worth of stock

Upcoming dividend of US$0.20 per share

CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Full year 2023 earnings: EPS misses analyst expectations

CONMED Corporation Provides Financial Guidance for the Full Year 2024

Investor sentiment deteriorates as stock falls 17%

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates fall by 11%

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Price target decreased by 9.5% to US$123

Third quarter 2023 earnings: EPS misses analyst expectations

CONMED Corporation Updates Third Quarter Guidance for 2023

CONMED Corporation to Report Q3, 2023 Results on Oct 25, 2023

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Upcoming dividend of US$0.20 per share at 0.7% yield

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

CONMED Corporation Revises Earnings Guidance for the Full Year 2023

CONMED Corporation to Report Q2, 2023 Results on Jul 26, 2023

Insider notifies of intention to sell stock

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Upcoming dividend of US$0.20 per share at 0.6% yield

CONMED Corporation Announces Quarterly Cash Dividend, Payable on July 5, 2023

Insider notifies of intention to sell stock

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Insider recently sold US$166k worth of stock

Price target increased by 13% to US$126

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chairman of the Board recently sold US$464k worth of stock

Executive VP & CFO exercised options and sold US$1.2m worth of stock

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Upcoming dividend of US$0.20 per share at 0.8% yield

Special Counsel & Corporate Secretary exercised options and sold US$283k worth of stock

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased by 11% to US$110

CONMED Corporation Provides Earnings Guidance for the Full Year 2023

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

CONMED Corporation to Report Q4, 2022 Results on Feb 02, 2023

Executive VP & CFO exercised options and sold US$174k worth of stock